NCT03773315

Ulmus Macrocarpa Hance Extract and Lipid Profile

Effect of Ulmus Macrocarpa Hance Extract on Lipid Profile in Adults With Dyslipidemia: a RCT

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Sang Yeoup Lee · Academic / Other
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Ulmus Macrocarpa Hance extract on lipid profile in adults with dyslipidemia for 12 weeks.

Detailed description

Previous another our study have indicated that Ulmus Macrocarpa Hance extract (UMH) may have the ability to decrease blood cholesterol. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the UMH on lipid profile in adults with dyslipidemia; the safety of the compound are also evaluate. The Investigators examine total cholesterol, HDL-cholesterol, triglyceridemia, LDL-cholesterol, and other biochemical parameters at baseline, as well as after 6 and 12 weeks of intervention. Eighty adults were administered either 500 mg of UMH or a placebo each day for 12 weeks;

Conditions

• Dyslipidemias

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	UMH extract	Schisandra chinensis extract 500 mg/day for 12 weeks
DIETARY_SUPPLEMENT	Placebo	Starch placebo 500 mg/day for 12 weeks

Timeline

• Start date: 2018-12-01
• Primary completion: 2020-02-14
• Completion: 2020-02-28
• First posted: 2018-12-12
• Last updated: 2021-04-28

Locations

1 site across 1 country: South Korea